Repligen
RGEN
#1945
Rank
โ‚ฌ9.25 B
Marketcap
145,83ย โ‚ฌ
Share price
-2.02%
Change (1 day)
11.85%
Change (1 year)
Categories

Earnings for Repligen (RGEN)

Earnings in 2026 (TTM): โ‚ฌ63.85 Million

According to Repligen 's latest financial reports the company's current earnings are โ‚ฌ0.78 Billion. In 2025 the company made an earning of โ‚ฌ74.67 Million, an increase over its 2024 earnings that were of -โ‚ฌ5.62 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Repligen from 1985 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚ฌ63.85 M-14.49%
2025 โ‚ฌ74.67 M-1430.84%
2024 -โ‚ฌ5.62 Million-113.01%
2023 โ‚ฌ43.12 M-78.01%
2022 โ‚ฌ0.19 B33.37%
2021 โ‚ฌ0.14 B131.52%
2020 โ‚ฌ63.5 M101.31%
2019 โ‚ฌ31.54 M25.93%
2018 โ‚ฌ25.05 M105.61%
2017 โ‚ฌ12.18 M-11.46%
2016 โ‚ฌ13.76 M14.91%
2015 โ‚ฌ11.97 M20.26%
2014 โ‚ฌ9.95 M-51.49%
2013 โ‚ฌ20.52 M90.98%
2012 โ‚ฌ10.74 M
2010 โ‚ฌ0.15 M-103.81%
2009 -โ‚ฌ4.09 Million-223.84%
2008 โ‚ฌ3.29 M
2006 -โ‚ฌ2.22 Million229.64%
2005 -โ‚ฌ0.68 Million-89.16%
2004 -โ‚ฌ6.21 Million-16.86%
2003 -โ‚ฌ7.46 Million88.72%
2002 -โ‚ฌ3.96 Million-27.88%
2001 -โ‚ฌ5.48 Million-1.74%
2000 -โ‚ฌ5.58 Million85.93%
1999 -โ‚ฌ3 Million159.16%
1998 -โ‚ฌ1.16 Million85.71%
1997 -โ‚ฌ0.63 Million-70.83%
1996 -โ‚ฌ2.14 Million-72.41%
1995 -โ‚ฌ7.75 Million-60.63%
1994 -โ‚ฌ19.68 Million45.39%
1993 -โ‚ฌ13.53 Million39.45%
1992 -โ‚ฌ9.71 Million-32.3%
1991 -โ‚ฌ14.34 Million6.62%
1990 -โ‚ฌ13.45 Million1577.78%
1989 -โ‚ฌ0.81 Million-57.14%
1988 -โ‚ฌ1.87 Million-362.5%
1987 โ‚ฌ0.71 M-130.77%
1986 -โ‚ฌ2.32 Million136.36%
1985 -โ‚ฌ0.98 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚ฌ6.14 B 9,196.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚ฌ6.79 B 10,178.60%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
โ‚ฌ10.19 B 15,310.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ10.60 B 15,929.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-โ‚ฌ98.2 Million-248.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-โ‚ฌ0.2 Billion-400.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚ฌ0.72 B 1,001.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
โ‚ฌ0.22 B 236.89%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ0.13 B 100.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
-โ‚ฌ0.17 Billion-347.20%๐Ÿ‡บ๐Ÿ‡ธ USA